MOG
Reactivity: Human
WB
Host: Mouse
Polyclonal
unconjugated
Application Notes
Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000,ELISA 1:5000-20000
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 %BSA
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Expiry Date
12 months
Target
MOG
(Myelin Oligodendrocyte Glycoprotein (MOG))
Alternative Name
MOG
Background
Myelin-oligodendrocyte glycoproteinMOG (Myelin Oligodendrocyte Glycoprotein) is a Protein Coding gene. Diseases associated with MOG include Narcolepsy 7 and Narcolepsy. Among its related pathways are Neural Stem Cell Differentiation Pathways and Lineage-specific Markers. The product of MOG is a membrane protein expressed on the oligodendrocyte cell surface and the outermost surface of myelin sheaths. Due to this localization, it is a primary target antigen involved in immune-mediated demyelination. This protein may be involved in completion and maintenance of the myelin sheath and in cell-cell communication.